ethyl methanesulfonate has been researched along with tyrosine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koike, T; Takashima, A | 1 |
| Hung, MC; Reardon, DB | 1 |
| Chen, JG; Rudnick, G; Sachpatzidis, A | 1 |
| Torres, VI; Weiss, DS | 1 |
| Desai, C; Purdy, J | 1 |
| Beaulieu, ME; Boucard, AA; Escher, E; Guillemette, G; Lavigne, P; Leduc, R; Roy, M | 1 |
| Alexeyev, MF; Audia, JP; Daugherty, RM; Roberts, RA; Winkler, HH | 1 |
| Agapova, LS; Chumakov, PM; Kopnin, BP; Volodina, JL | 1 |
| Boucard, AA; Clément, M; Escher, E; Guillemette, G; Leduc, R; Martin, SS | 1 |
9 other study(ies) available for ethyl methanesulfonate and tyrosine
| Article | Year |
|---|---|
Clonal variability of PC12 pheochromocytoma cells with respect to catecholamine biosynthesis.
Topics: Adrenal Gland Neoplasms; Animals; Cell Line; Chromatography, High Pressure Liquid; Clone Cells; Dexamethasone; Dopamine; Ethyl Methanesulfonate; Kinetics; Norepinephrine; Pheochromocytoma; Rats; Tyrosine | 1984 |
Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene.
Topics: 3T3 Cells; Animals; Blotting, Southern; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; DNA; Ethyl Methanesulfonate; Mice; Mutagenesis; Oncogenes; Phosphotyrosine; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogenes; Receptor, ErbB-2; Receptors, Cell Surface; Restriction Mapping; Signal Transduction; Tyrosine | 1993 |
The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding.
Topics: Asparagine; Binding Sites; Carrier Proteins; Cell Line; Cell Membrane; Cocaine; Cysteine; Ethyl Methanesulfonate; Humans; Indicators and Reagents; Isoleucine; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Mesylates; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Protein Structure, Secondary; Serotonin; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Tyrosine | 1997 |
Identification of a tyrosine in the agonist binding site of the homomeric rho1 gamma-aminobutyric acid (GABA) receptor that, when mutated, produces spontaneous opening.
Topics: Amino Acid Sequence; Animals; Binding Sites; Binding, Competitive; Crotonates; Dimerization; Dose-Response Relationship, Drug; Electrophysiology; Ethyl Methanesulfonate; GABA Antagonists; Glycine; Humans; Imidazoles; Mesylates; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Oocytes; Organophosphorus Compounds; Picrotoxin; Protein Binding; Receptors, GABA-B; RNA, Complementary; Serine; Transcription, Genetic; Tryptophan; Tyrosine; Xenopus laevis | 2002 |
The neural receptor protein tyrosine phosphatase DPTP69D is required during periods of axon outgrowth in Drosophila.
Topics: Alleles; Animals; Axons; Crosses, Genetic; Drosophila; Drosophila Proteins; Ethyl Methanesulfonate; Gene Deletion; Genotype; Heterozygote; Homozygote; Immunohistochemistry; Models, Genetic; Muscles; Mutagenesis; Mutagens; Mutation; Neurons; Phenotype; Phosphorylation; Protein Structure, Tertiary; Protein Tyrosine Phosphatases; Receptor-Like Protein Tyrosine Phosphatases; Signal Transduction; Structure-Activity Relationship; Temperature; Time Factors; Tyrosine | 2003 |
Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket.
Topics: Amino Acid Sequence; Animals; Binding Sites; Cell Membrane; COS Cells; Cysteine; Dose-Response Relationship, Drug; Ethyl Methanesulfonate; Genes, Reporter; Humans; Isoleucine; Kinetics; Ligands; Mesylates; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Oligonucleotides; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Receptor, Angiotensin, Type 1; Sequence Homology, Amino Acid; Transfection; Tyrosine; Water | 2003 |
Cysteine-scanning mutagenesis and thiol modification of the Rickettsia prowazekii ATP/ADP translocase: evidence that transmembrane regions I and II, but not III, are structural components of the aqueous translocation channel.
Topics: Amino Acid Sequence; Amino Acid Substitution; Cysteine; Ethyl Methanesulfonate; Ion Channel Gating; Isoleucine; Mesylates; Mitochondrial ADP, ATP Translocases; Molecular Sequence Data; Mutagenesis; Mutation; Phenylalanine; Rickettsia prowazekii; Sequence Homology, Amino Acid; Sulfhydryl Compounds; Translocation, Genetic; Tyrosine | 2004 |
Activation of Ras-Ral pathway attenuates p53-independent DNA damage G2 checkpoint.
Topics: Blotting, Western; CDC2 Protein Kinase; Cell Line, Tumor; Cell Separation; Cyclin B; Cyclin B1; DNA; DNA Damage; Doxorubicin; Ethyl Methanesulfonate; Fibroblasts; Flow Cytometry; G1 Phase; G2 Phase; Genes, Dominant; Humans; Microscopy, Fluorescence; Mitosis; Mutation; Osteosarcoma; Phosphatidylinositol 3-Kinases; Phosphorylation; Precipitin Tests; ral Guanine Nucleotide Exchange Factor; ras Proteins; Retroviridae; Signal Transduction; Thymidine; Time Factors; Tumor Suppressor Protein p53; Tyrosine | 2004 |
Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis.
Topics: Amino Acid Sequence; Animals; Binding Sites; COS Cells; Cysteine; DNA, Complementary; Dose-Response Relationship, Drug; Ethyl Methanesulfonate; Humans; Indicators and Reagents; Isoleucine; Kinetics; Ligands; Models, Biological; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Oligonucleotides; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Receptor, Angiotensin, Type 1; Tyrosine | 2004 |